PedAM
Pediatric Disease Annotations & Medicines
| psoriatic arthritis | ||||
| Disease ID | 663 |
|---|---|
| Disease | psoriatic arthritis |
| Manually Symptom | (Waiting for update.) |
| Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:27) C0033860 | psoriasis | 53 C1282952 | enthesitis | 7 C0239161 | dactylitis | 5 C0004153 | atherosclerosis | 5 C0030193 | pain | 4 C0038012 | spondylitis | 4 C0948265 | metabolic syndrome | 3 C0003864 | inflammatory arthritis | 3 C0009450 | infection | 3 C0039103 | synovitis | 3 C0029456 | osteoporosis | 2 C0027339 | nail disease | 2 C0037284 | skin lesions | 2 C0042164 | uveitis | 2 C0856169 | endothelial dysfunction | 2 C0022408 | joint disease | 2 C0032285 | pneumonitis | 1 C0013604 | oedema | 1 C0574960 | sacroiliitis | 1 C0015672 | fatigue | 1 C0221260 | nail dystrophy | 1 C0014118 | endocarditis | 1 C0034069 | pulmonary fibrosis | 1 C0333243 | pitting oedema | 1 C1301700 | cardiovascular morbidity | 1 C0270627 | acute transverse myelitis | 1 C0238790 | bone destruction | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
|---|
| (Waiting for update.) |
All Snps(Total Genotypes:44) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
| rs10181656 | 22328738 | 3798 | KIF5A | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000271442 | 2012 | STAT4 | 2 | 191105153 | G | C |
| rs10181656 | 22328738 | 6366 | CCL21 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000271442 | 2012 | STAT4 | 2 | 191105153 | G | C |
| rs10181656 | 22328738 | 6775 | STAT4 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000271442 | 2012 | STAT4 | 2 | 191105153 | G | C |
| rs10181656 | 22328738 | 3899 | AFF3 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000542884 | 2012 | STAT4 | 2 | 191105153 | G | C |
| rs10181656 | 22328738 | 3558 | IL2 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000542884 | 2012 | STAT4 | 2 | 191105153 | G | C |
| rs10181656 | 22328738 | 940 | CD28 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000271442 | 2012 | STAT4 | 2 | 191105153 | G | C |
| rs10181656 | 22328738 | 23228 | PLCL2 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000271442 | 2012 | STAT4 | 2 | 191105153 | G | C |
| rs11171806 | 23673284 | 51561 | IL23A | umls:C0003872 | BeFree | Association study in Romanians confirms IL23A gene haplotype block rs2066808/rs11171806 as conferring risk to psoriatic arthritis. | 0.007077352 | 2013 | IL23A | 12 | 56339747 | G | A |
| rs11209026 | 19040306 | 5079 | PAX5 | umls:C0003872 | BeFree | All 3-marker sliding windows containing SNP rs11209026 were associated with PsA (p=0.02 for all 3 windows). | 0.000271442 | 2009 | IL23R | 1 | 67240275 | G | A |
| rs12188300 | 20953186 | 3593 | IL12B | umls:C0003872 | GAD | [We replicated PsA associations at HLA-C and IL12B and identified a new association at TRAF3IP2 (rs13190932, P = 8.56 A 10a>>A1a*).] | 0.135178339 | 2010 | NA | 5 | 159402519 | A | T |
| rs13017599 | 22328738 | 3798 | KIF5A | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000271442 | 2012 | NA | 2 | 60937196 | G | A |
| rs13017599 | 22328738 | 6366 | CCL21 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000271442 | 2012 | NA | 2 | 60937196 | G | A |
| rs13017599 | 22170493 | 5966 | REL | umls:C0003872 | GWASCAT | Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL. | 0.123452799 | 2012 | NA | 2 | 60937196 | G | A |
| rs13017599 | 22328738 | 3558 | IL2 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000542884 | 2012 | NA | 2 | 60937196 | G | A |
| rs13017599 | 22328738 | 6775 | STAT4 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000271442 | 2012 | NA | 2 | 60937196 | G | A |
| rs13017599 | 22328738 | 3899 | AFF3 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000542884 | 2012 | NA | 2 | 60937196 | G | A |
| rs13017599 | 22328738 | 23228 | PLCL2 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000271442 | 2012 | NA | 2 | 60937196 | G | A |
| rs13017599 | 22170493 | 5966 | REL | umls:C0003872 | GAD | [Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL.] | 0.123452799 | 2012 | NA | 2 | 60937196 | G | A |
| rs13017599 | 22328738 | 940 | CD28 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000271442 | 2012 | NA | 2 | 60937196 | G | A |
| rs13190932 | 20953186 | 3593 | IL12B | umls:C0003872 | BeFree | We replicated PsA associations at HLA-C and IL12B and identified a new association at TRAF3IP2 (rs13190932, P = 8.56 × 10⁻¹⁷). | 0.135178339 | 2010 | TRAF3IP2;TRAF3IP2-AS1 | 6 | 111591867 | G | A |
| rs13190932 | 20953186 | 3107 | HLA-C | umls:C0003872 | BeFree | We replicated PsA associations at HLA-C and IL12B and identified a new association at TRAF3IP2 (rs13190932, P = 8.56 × 10⁻¹⁷). | 0.289478499 | 2010 | TRAF3IP2;TRAF3IP2-AS1 | 6 | 111591867 | G | A |
| rs13191343 | 20953186 | 3107 | HLA-C | umls:C0003872 | GWASCAT | We replicated PsA associations at HLA-C and IL12B and identified a new association at TRAF3IP2 (rs13190932, P = 8.56 × 10⁻¹⁷). | 0.289478499 | 2010 | HLA-C;LOC101929772 | 6 | 31273332 | C | G,T |
| rs13191343 | 20953186 | 3107 | HLA-C | umls:C0003872 | GAD | [We replicated PsA associations at HLA-C and IL12B and identified a new association at TRAF3IP2 (rs13190932, P = 8.56 A 10a>>A1a*).] | 0.289478499 | 2010 | HLA-C;LOC101929772 | 6 | 31273332 | C | G,T |
| rs1801282 | 24697566 | 5468 | PPARG | umls:C0003872 | BeFree | Meta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis. | 0.002909916 | 2014 | PPARG | 3 | 12351626 | C | G |
| rs1805192 | 24697566 | 5468 | PPARG | umls:C0003872 | BeFree | Meta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis. | 0.002909916 | 2014 | PPARG | 3 | 12379739 | C | G |
| rs2066808 | 23673284 | 51561 | IL23A | umls:C0003872 | BeFree | Association study in Romanians confirms IL23A gene haplotype block rs2066808/rs11171806 as conferring risk to psoriatic arthritis. | 0.007077352 | 2013 | STAT2 | 12 | 56344189 | A | G |
| rs2201841 | 24910145 | 149233 | IL23R | umls:C0003872 | BeFree | IL-23R gene polymorphism rs2201841 is associated with psoriatic arthritis. | 0.015721222 | 2014 | IL23R | 1 | 67228519 | A | G |
| rs2631367 | 16255050 | 6584 | SLC22A5 | umls:C0003872 | BeFree | In contrast, a functional SNP mapping to the promoter region of SLC22A5 (rs2631367) was associated with PsA (for CC versus GG, odds ratio 1.65, 95% confidence interval 1.13-2.41, uncorrected P = 0.005). | 0.002638474 | 2005 | SLC22A5;LOC553103 | 5 | 132369766 | C | G |
| rs3212227 | 23297015 | 3593 | IL12B | umls:C0003872 | BeFree | Meta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis. | 0.135178339 | 2012 | IL12B | 5 | 159315942 | T | G |
| rs3212227 | 18800148 | 3593 | IL12B | umls:C0003872 | BeFree | For both PA and PV, we detected the strongest association with two IL12B single-nucleotide polymorphisms and the corresponding haplotype as reflected by minimal P-values of 10(-7) and highest odds ratios of 1.50 (1.28-1.75) for rs6887695 in PA patients and 1.50 (1.27-1.76) for rs3212227 in the PV cohort, respectively. | 0.135178339 | 2009 | IL12B | 5 | 159315942 | T | G |
| rs33980500 | 20953188 | 10758 | TRAF3IP2 | umls:C0003872 | BeFree | A stratified analysis of our datasets including only PsA cases (1,922 cases compared to 8,037 controls, P = 4.57 × 10⁻¹² for rs33980500) suggested that TRAF3IP2 represents a shared susceptibility for PsV and PsA. | 0.246634157 | 2010 | TRAF3IP2;TRAF3IP2-AS1 | 6 | 111592059 | C | T |
| rs33980500 | 20953186 | 643749 | TRAF3IP2-AS1 | umls:C0003872 | GWASCAT | Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. | 0.12 | 2010 | TRAF3IP2;TRAF3IP2-AS1 | 6 | 111592059 | C | T |
| rs33980500 | 20953186 | 10758 | TRAF3IP2 | umls:C0003872 | GWASCAT | Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. | 0.246634157 | 2010 | TRAF3IP2;TRAF3IP2-AS1 | 6 | 111592059 | C | T |
| rs33980500 | 20953186 | 10758 | TRAF3IP2 | umls:C0003872 | GAD | [Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis.] | 0.246634157 | 2010 | TRAF3IP2;TRAF3IP2-AS1 | 6 | 111592059 | C | T |
| rs4535211 | 22328738 | 6775 | STAT4 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000271442 | 2012 | PLCL2 | 3 | 17031505 | A | G |
| rs4535211 | 22328738 | 3798 | KIF5A | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000271442 | 2012 | PLCL2 | 3 | 17031505 | A | G |
| rs4535211 | 22328738 | 3899 | AFF3 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000542884 | 2012 | PLCL2 | 3 | 17031505 | A | G |
| rs4535211 | 22328738 | 6366 | CCL21 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000271442 | 2012 | PLCL2 | 3 | 17031505 | A | G |
| rs4535211 | 22328738 | 23228 | PLCL2 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000271442 | 2012 | PLCL2 | 3 | 17031505 | A | G |
| rs4535211 | 22328738 | 3558 | IL2 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000542884 | 2012 | PLCL2 | 3 | 17031505 | A | G |
| rs4535211 | 22328738 | 940 | CD28 | umls:C0003872 | BeFree | Significant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci. | 0.000271442 | 2012 | PLCL2 | 3 | 17031505 | A | G |
| rs6887695 | 23297015 | 3593 | IL12B | umls:C0003872 | BeFree | Meta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis. | 0.135178339 | 2012 | NA | 5 | 159395637 | G | C |
| rs6887695 | 18800148 | 3593 | IL12B | umls:C0003872 | BeFree | For both PA and PV, we detected the strongest association with two IL12B single-nucleotide polymorphisms and the corresponding haplotype as reflected by minimal P-values of 10(-7) and highest odds ratios of 1.50 (1.28-1.75) for rs6887695 in PA patients and 1.50 (1.27-1.76) for rs3212227 in the PV cohort, respectively. | 0.135178339 | 2009 | NA | 5 | 159395637 | G | C |
| rs702873 | 22170493 | 400957 | LINC01185 | umls:C0003872 | GWASCAT | Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL. | 0.12 | 2012 | LINC01185 | 2 | 60854407 | C | T |
GWASdb Annotation(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Snp Trait(Total Genotypes:5) | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CHR | POS | SNPID | REF | ALT | ORI_SNPID | PMID | P_VALUE | P_VALUE_TEXT | OR/BETA | CI95_TEXT | GWAS_INITIAL_SAMPLE_SIZE | SUB_POPULATION | SUPER_POPULATION | GWAS_TRAIT | HPO_ID | HPO_TERM | DO_ID | DO_TERM | MESH_ID | MESH_TERM | EFO_ID | EFO_TERM | DOLITE_TERM | RISK_ALLELE | PUBLICATION_TYPE | AA | GENE_SYMBOL | TYPE | REFGENE |
| 2 | 61081542 | rs702873 | C | T | rs702873 | 22170493 | 2.00E-07 | NA | 1.2 | [1.13-1.28] | 535 European ancestry cases; 3,432 European ancestry controls | European(3967) | ALL(3967) | EUR(3967) | ALL(3967) | Psoriatic arthritis | HPOID:0003765 | HPOID:0001369 | Psoriasis | Arthritis | DOID:9008 | psoriatic arthritis | D015535 | Arthritis, Psoriatic | EFOID:0003778 | psoriatic arthritis | Psoriasis | Arthritis | NA |
| 2 | 61164331 | rs13017599 | G | A | rs13017599 | 22170493 | 1.00E-08 | NA | 1.27 | [1.18-1.35] | 535 European ancestry cases; 3,432 European ancestry controls | European(3967) | ALL(3967) | EUR(3967) | ALL(3967) | Psoriatic arthritis | HPOID:0003765 | HPOID:0001369 | Psoriasis | Arthritis | DOID:9008 | psoriatic arthritis | D015535 | Arthritis, Psoriatic | EFOID:0003778 | psoriatic arthritis | Psoriasis | Arthritis | NA |
| 5 | 158829527 | rs12188300 | A | T | rs12188300 | 20953186 | 7.00E-17 | NA | 1.7 | [1.50-1.93] | 572 German cases; 888 German controls | German(1460) | ALL(1460) | EUR(1460) | ALL(1460) | Psoriatic arthritis | HPOID:0003765 | HPOID:0001369 | Psoriasis | Arthritis | DOID:9008 | psoriatic arthritis | D015535 | Arthritis, Psoriatic | EFOID:0003778 | psoriatic arthritis | Psoriasis | Arthritis | rs12188300-T |
| 6 | 31241109 | rs13191343 | C | T | rs13191343 | 20953186 | 2.00E-72 | NA | 2.37 | [2.16-2.61] | 572 German cases; 888 German controls | German(1460) | ALL(1460) | EUR(1460) | ALL(1460) | Psoriatic arthritis | HPOID:0003765 | HPOID:0001369 | Psoriasis | Arthritis | DOID:9008 | psoriatic arthritis | D015535 | Arthritis, Psoriatic | EFOID:0003778 | psoriatic arthritis | Psoriasis | Arthritis | rs13191343-T |
| 6 | 111913262 | rs33980500 | C | T | rs33980500 | 20953186 | 1.00E-20 | NA | 1.95 | [1.69-2.24] | 572 German cases; 888 German controls | German(1460) | ALL(1460) | EUR(1460) | ALL(1460) | Psoriatic arthritis | HPOID:0003765 | HPOID:0001369 | Psoriasis | Arthritis | DOID:9008 | psoriatic arthritis | D015535 | Arthritis, Psoriatic | EFOID:0003778 | psoriatic arthritis | Psoriasis | Arthritis | rs33980500-T |
Mapped by lexical matching(Total Items:0) |
|---|
| (Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
|---|
| (Waiting for update.) |
Chemical(Total Drugs:5) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
| C0003872 | acitretin | D017255 | 55079-83-9 | arthritis, psoriatic | MESH:D015535 | therapeutic | 14746632 | ||
| C0003872 | colchicine | D003078 | 64-86-8 | arthritis, psoriatic | MESH:D015535 | therapeutic | 17408446 | ||
| C0003872 | diclofenac | D004008 | 15307-86-5 | arthritis, psoriatic | MESH:D015535 | therapeutic | 7487376 | ||
| C0003872 | folic acid | D005492 | 59-30-3 | arthritis, psoriatic | MESH:D015535 | therapeutic | 17190135 | ||
| C0003872 | methotrexate | D008727 | 1959/5/2 | arthritis, psoriatic | MESH:D015535 | therapeutic | 11771523 | ||
FDA approved drug and dosage information(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |
FDA labeling changes(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |